000 | 01093 a2200325 4500 | ||
---|---|---|---|
005 | 20250511124116.0 | ||
264 | 0 | _c19780925 | |
008 | 197809s 0 0 eng d | ||
022 | _a0009-9104 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChapuis, B J | |
245 | 0 | 0 |
_aInability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cMay 1978 |
||
300 |
_a253-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies _xanalysis |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRemission, Spontaneous |
700 | 1 | _aPowles, R | |
700 | 1 | _aAlexander, P | |
773 | 0 |
_tClinical and experimental immunology _gvol. 32 _gno. 2 _gp. 253-8 |
|
999 |
_c301706 _d301706 |